Diarrhea News and Research

Latest Diarrhea News and Research

DanActive drink reduces rate of common sicknesses in daycare children, say researchers

The probiotic yogurt-like drink DanActive reduced the rate of common sicknesses such as ear infections, sinusitis, the flu and diarrhea in daycare children, say researchers who studied the drink in the largest known probiotic clinical trial to be conducted in the United States. An additional finding, however, showed no reduction in the number school days missed.

19 May 2010

GHESKIO awarded prestigious 2010 Gates Award for Global Health

GHESKIO, an institution in Haiti founded nearly three decades ago to fight a mysterious killer disease later identified as AIDS, has been awarded the prestigious 2010 Gates Award for Global Health for its years of groundbreaking clinical service, research and training to effectively treat and prevent the spread of the HIV/AIDS and other related illnesses.

19 May 2010

GHESKIO honored with 2010 Gates Award for Global Health

GHESKIO, an institution in Haiti founded nearly three decades ago to fight a mysterious killer disease later identified as AIDS, has been awarded the prestigious 2010 Gates Award for Global Health for its years of ground-breaking clinical service, research, and training to treat effectively and prevent the spread of the HIV/AIDS and other related illnesses, the Global Health Council announced today.

18 May 2010

High-fat ketogenic diet effective in treating infantile spasms

The high-fat ketogenic diet can dramatically reduce or completely eliminate debilitating seizures in most children with infantile spasms, whose seizures persist despite medication, according to a Johns Hopkins Children's Center study published online April 30 in the journal Epilepsia.

18 May 2010

Is gluten the latest villain in the battle for better health?

If you've been food shopping or out to eat lately, you've probably noticed that "gluten-free" foods now claim their own grocery store shelves and dozens of national restaurant chain menus highlight "gluten-free" entrees.

17 May 2010

U.S. healthcare practitioners can resume use of Rotarix, says FDA

GlaxoSmithKline announced that the Food and Drug Administration has determined that U.S. healthcare practitioners can resume the use of Rotarix (Rotavirus Vaccine, Live, Oral), effective immediately. This action supersedes the FDA's recommendation from March 22, 2010 and reflects the agency's assessment that the presence of porcine circovirus type 1 in the vaccine poses no safety risk.

15 May 2010

Leaving food out in the sun can put you at risk for food-borne illness

Leaving food out in the sun too long can put a damper on your summer picnic.

14 May 2010

Rotavirus vaccination associated with decline in U.S. hospitalization rates for acute gastroenteritis: Study

Vaccinating infants against rotavirus, a leading cause of severe diarrhea and dehydration among babies and young children, was associated with a dramatic decline in U.S. hospitalization rates for acute gastroenteritis.

14 May 2010

Nationwide Children's Hospital offers new gastric sleeve surgical weight loss procedure

A new weight reduction surgical option is now available through the Center for Healthy Weight and Nutrition at Nationwide Children's Hospital. The newest surgical weight loss procedure offered by the Center is the "gastric sleeve," named as such because a large part of the stomach is removed and the remainder is closed to make a tube-like "sleeve."

14 May 2010

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.

13 May 2010

Two-thirds of child deaths in 2008 due to infectious diseases, report finds

Pneumonia, diarrhea, malaria and other infectious diseases accounted for two-thirds of the 8.8 million deaths in 2008 among children under age 5 around the world, according to a Lancet study published on Wednesday, HealthDay News/Bloomberg BusinessWeek reports. The highest numbers of childhood deaths were in Africa (4.2 million) and Southeast Asia (2.39 million), according to the news service (5/11).

13 May 2010

Microbiologists identify potential target in cattle to prevent E. coli strain

Microbiologists at UT Southwestern Medical Center, working with the Department of Agriculture, have identified a potential target in cattle that could be exploited to help prevent outbreaks of food-borne illnesses caused by a nasty strain of Escherichia coli.

13 May 2010

Patient enrollment completed in Phase 2 clinical trial of orBec for prevention of acute GVHD

Soligenix, Inc., a late-stage biopharmaceutical company, announced today that patient enrollment has been completed in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of orBec for the prevention of acute Graft-versus-Host disease after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens.

12 May 2010

Preventable infectious diseases cause two-thirds of child deaths: The Lancet

Preventable infectious diseases cause two-thirds of child deaths, according to a new study published today by The Lancet. Experts from the World Health Organization and UNICEF's Child Health Epidemiology Reference Group assessed data from 193 countries to produce estimates by country, region and the world.

12 May 2010

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

Sanofi-aventis announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made during Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.

12 May 2010

FDA, CDC confirm connection between romaine lettuce and E.coli 0145 foodborne illness outbreak

The Food and Drug Administration (FDA), with the Centers for Disease Control and Prevention (CDC) and its state health partners have confirmed that the strain of E. coli O145 detected by the New York State Public Health Laboratory, Wadsworth Center, in Albany, in an unopened bag of shredded romaine lettuce distributed by Freshway Foods, matches the outbreak strain of E. coli O145.

11 May 2010

Intercell reports EUR 4.8m revenue, EUR 14.7m net loss for first-quarter 2010

Today, the biotech-vaccine company Intercell AG announced its financial results for Q1 and presented an update on the Company's development programs.

11 May 2010

Progenics Pharmaceuticals reports net loss of $18.6M in first-quarter 2010

Progenics Pharmaceuticals, Inc. today announced its results of operations for the quarter ended March 31, 2010.

11 May 2010

Sucampo presents phase 3 trial results of lubiprostone in non-cancer pain patients with OBD at DDW 2010

Sucampo Pharmaceuticals, Inc. today announced the presentation of results from a phase 3 clinical trial investigating the use of lubiprostone in non-cancer pain patients with Opioid-induced Bowel Dysfunction (OBD). These results were the subject of an oral presentation at the Digestive Disease Week (DDW) 2010 conference in New Orleans, Louisiana, on May 5, 2010.

11 May 2010

New York Times examines global fight against HIV/AIDS

Several articles in the New York Times examine the global fight against HIV/AIDS. "Uganda is the first country where major clinics routinely turn people away" because they lack funding, the newspaper writes in an article that reports "money for [HIV/AIDS] treatment has stopped growing."

11 May 2010

Diarrhea News and Research

Latest Diarrhea News and Research

DanActive drink reduces rate of common sicknesses in daycare children, say researchers

GHESKIO awarded prestigious 2010 Gates Award for Global Health

GHESKIO honored with 2010 Gates Award for Global Health

High-fat ketogenic diet effective in treating infantile spasms

Is gluten the latest villain in the battle for better health?

U.S. healthcare practitioners can resume use of Rotarix, says FDA

Leaving food out in the sun can put you at risk for food-borne illness

Rotavirus vaccination associated with decline in U.S. hospitalization rates for acute gastroenteritis: Study

Nationwide Children's Hospital offers new gastric sleeve surgical weight loss procedure

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Two-thirds of child deaths in 2008 due to infectious diseases, report finds

Microbiologists identify potential target in cattle to prevent E. coli strain

Patient enrollment completed in Phase 2 clinical trial of orBec for prevention of acute GVHD

Preventable infectious diseases cause two-thirds of child deaths: The Lancet

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

FDA, CDC confirm connection between romaine lettuce and E.coli 0145 foodborne illness outbreak

Intercell reports EUR 4.8m revenue, EUR 14.7m net loss for first-quarter 2010

Progenics Pharmaceuticals reports net loss of $18.6M in first-quarter 2010

Sucampo presents phase 3 trial results of lubiprostone in non-cancer pain patients with OBD at DDW 2010

New York Times examines global fight against HIV/AIDS

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Diarrhea News and Research

Latest Diarrhea News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in